An international team led by the Josep Carreras Leukaemia Research Institute (IJC) in Barcelona, the Centre for Genomics and Oncological Research (GENyO) and the University of Granada (UGR) has identified a new biological vulnerability in one of the most aggressive forms of childhood leukemia. The findings could pave the way for new therapeutic strategies for patients who currently have very…
Source: Medical Xpress
